Su Deng

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Neuroendocrine Differentiation in Prostate Cancer Requires ASCL1”.

Neuroendocrine Differentiation in Prostate Cancer Requires ASCL1

Cancer Research(2024)10.1158/0008-5472.can-24-1388

N/A

0.924DataRank · unranked

36 citations

Shaked Nir Heyman, Lei Guo, Lydia Flores, Trisha K. Savage, Juan Villarreal +6 more

Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance

Nature Cancer(2022)10.1038/s43018-022-00431-9

N/A

0DataRank · unranked

152 citations

Choushi Wang, Yunguan Wang, Yaru Xu, Xiaoling Li, Nickolas A. Johnson +21 more

ApoE isoform– and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy

Science(2023)10.1126/science.add1236

N/A

0DataRank · unranked

247 citations

David O’Donnell, Nimansha Jain, Jason D. Ulrich, Jasmin Herz, Yuhao Li +18 more

Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer

Cancer Cell(2023)10.1016/j.ccell.2023.06.010

N/A

0DataRank · unranked

52 citations

Yunguan Wang, Su Deng, Guanghui Zhu, Choushi Wang, Nickolas A. Johnson +26 more

UBE2J1 is the E2 ubiquitin-conjugating enzyme regulating androgen receptor degradation and antiandrogen resistance

Oncogene(2023)10.1038/s41388-023-02890-5

N/A

0DataRank · unranked

18 citations

Choushi Wang, Xiaoling Li, Su Deng, Julisa Gonzalez, Nickolas A. Johnson +15 more

ZNF397 Loss Triggers TET2-driven Epigenetic Rewiring, Lineage Plasticity, and AR-targeted Therapy Resistance in AR-dependent Cancers

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.24.563645

N/A

0DataRank · unranked

0 citations

Zhaoning Wang, Martin Sjöström, Su Deng, Choushi Wang, Nickolas A. Johnson +22 more

Hyd/UBR5 defines a tumor suppressor pathway that links Polycomb repressive complex to regulated protein degradation in tissue growth control and tumorigenesis

Genes & Development(2024)10.1101/gad.351856.124

N/A

0DataRank · unranked

5 citations

Huiyan Lei, Hua Deng, Su Deng, Carla R. Tirado, Meiling Wang +4 more

Pan-cancer Analysis Identified Ectopic RUNX1T1 Associated with Lineage Plasticity

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.18.649575

N/A

0DataRank · unranked

3 citations

Siyuan Cheng, Isaac Yi Kim, Su Deng, Ping Mu, Yuyin Jiang

Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation

Cancer Cell(2020)10.1016/j.ccell.2020.03.001

N/A

0DataRank · unranked

166 citations

Chuanli Zhou, Xiaoling Li, Spencer Barnes, Su Deng, Elizabeth Hoover +27 more

Notch as a Driver of Lineage Plasticity and Therapeutic Target in Enzalutamide-Resistant Prostate Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.26.656166

N/A

0DataRank · unranked

3 citations

Siyuan Cheng, Linqing Li, Melanie Fraidenburg, Isaac Yi Kim, Su Deng +2 more